首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Human EPO Protein, Fc Tag

Human EPO Protein, Fc Tag

产品编号

KMPH1383

别名

促红细胞生成素, Erythropoietin, EPO, human EPO, human Erythropoietin, EPO Protein, human EPO Protein

规格
  • 100ug
  • 1mg
产品介绍
Alias促红细胞生成素, Erythropoietin, EPO, human EPO, human Erythropoietin, EPO Protein, human EPO Protein
Catalog NumberKMPH1383
Molecular NameErythropoietin, EPO
SpeciesHuman
HostHEK293 Cells
Size100ug, 1mg
Purity> 95% as determined by Tris-Bis PAGE, > 95% as determined by HPLC
Endotoxin< 10 EU per mg protein.
FormulationLyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
BackgroundErythropoietin is a member of the EPO / TPO family. It is a secreted, glycosylated cytokine composed of four alpha helical bundles. Erythropoietin can be found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. It also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types. Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. It is produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals. Genetic variation in erythropoietin is associated with susceptbility to microvascular complications of diabetes type 2. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. It has a longer circulating half-life in vivo. Erythropoietin is being much misused as a performance-enhancing drug in endurance athletes.
ApplicationSDS-PAGE, WB, ELISA
TaghFc tag
Biological ActivityMeasured in a cell proliferation assay using TF-1 human erythroleukemic cells. The ED50 for this effect is 2.0-8.0 ng/mL.
Predicted N TerminusAla 28
ReconstitutionCentrifuge the tube before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage ConditionSamples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Shipping ConditionIn general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
SequenceMGVHECPAWLWLLLSLLSLPLGLPVLGAPPRLICDSRVLERYLLEAKEAEN ITTGCAEHCSLNENITVPDTKVNFYAWKRMEVGQQAVEVWQGLALLSEAVL RGQALLVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAISPPDAAS AAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEACRTGDR
Molecular WeightThe recombinant human EPO consists 404 amino acids and predicts a molecular mass of 45.1 kDa.
Uniprot IDP01588
Note仅供科研使用

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价